Epigral Ltd
NSE:EPIGRAL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
899.7
2 344.35
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Epigral Ltd
Epigral Ltd
Cost of Revenue
Epigral Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Epigral Ltd
NSE:EPIGRAL
|
Cost of Revenue
-₹12.2B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Supreme Industries Ltd
NSE:SUPREMEIND
|
Cost of Revenue
-₹72.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Tata Chemicals Ltd
NSE:TATACHEM
|
Cost of Revenue
-₹53.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
5%
|
|
|
Deepak Nitrite Ltd
NSE:DEEPAKNTR
|
Cost of Revenue
-₹59.7B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Berger Paints India Ltd
NSE:BERGEPAINT
|
Cost of Revenue
-₹66.8B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-11%
|
|
|
Solar Industries India Ltd
NSE:SOLARINDS
|
Cost of Revenue
-₹31B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-17%
|
|
Epigral Ltd
Glance View
Meghmani Finechem Ltd. engages in the manufacture of chemicals involved in pigments and pesticides. The company is headquartered in Ahmedabad, Gujarat and currently employs 936 full-time employees. The company went IPO on 2021-08-18. The firm is engaged in manufacturing and selling chlor alkali and its derivatives. The company is also engaged in the trading of agrochemical products. The firm manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.
See Also
What is Epigral Ltd's Cost of Revenue?
Cost of Revenue
-12.2B
INR
Based on the financial report for Mar 31, 2024, Epigral Ltd's Cost of Revenue amounts to -12.2B INR.
What is Epigral Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-43%
Over the last year, the Cost of Revenue growth was 5%. The average annual Cost of Revenue growth rates for Epigral Ltd have been -43% over the past three years .
You don't have any saved screeners yet
